Are you suggesting management did not put us in this 'enviable' position?
You do realize the most you can now lose per share is 36 cents?
Do you own another security where your maximum losses per share are limited to 36 cents?.
Clearly management should be rewarded for their creativity in limiting future per share losses for shareholders! Those guys never stop thinking about their shareholders!
And never happier to be wrong.
An 8% drop from yesterday's results announcement is spectacularly positive. The market has not thrown in the towel. We may drop another 5 or 10% in coming days but that's nothing compared to what I expected.
Tomorrow US markets are going to suffer their worst blood bath in many years. Today was the expected head-fake which always accompanies market collapses.
Toady CCUR informed us theyt completely screwed up last quarter to the point where revs came in 35% below expectations with no warning.
In the circumstances it's possible CCUR could hit a pps under 50% of its net cash value
Decision time for CCUR longs..
Load up at 50c in the dollar and hope CCUR can get a new CEO or let it go....
What to do, what to do????
With this kind of performance, the dividend strategy will have to change but yes we get the 12c dividend together with our new CEO's present for his first qtr of (I'm guessing) about $3 pps loss.
Bummer. I think we need to seriously consider the possibility we made a bad mistake with our CEO selection. Another quarter like this one would spell the end for CCUR.
Revs dropped 34% and we're back to making losses.
In the current market environment, we will see a minimum 60% haircut IMHO.
Tough news. Tomorrow will not be good.
The last time oil was down here the imbalance in supply and demand was just a fraction of what it is today.
We now know oil has to go a lot lower to force producers to cut production. there's no way current supply can be consumed.
Clearly mgt is doing a good job, putting the company in a place where it's impervious to large market corrections!
No, it's just a regular market correction. It's like waking up in the morning. Many people find it boring but consider the alternative!
What's the point watching headless chickens running in random directions, I mean Wall Street.
needs to be fired
Close to no risk of deal not closing and a good chance of a counter offer and/or a bidding war. Dot Hill technology matches EMC in the small/medium sector but is far cheaper. They are a fast-growing, cutting-edge storage company with a pristine balance sheet.
Seagate is a $15B company with a history of acquisitions and is unlikely to declare they made a mistake offering to buy HILL. Notice Seagate used the word 'strategic'. They cannot declare 3 months from now they did not understand the industry when they said that. They do understand the industry and they know the strategic importance of HILL.
In situations like these, the only way the deal fails to close is if the buyer turns up some shenanigans in HILL's books but remember HILL has a clean balance sheet and conservative financial management/reporting.
I think we see at least another offer and HILL is taken out north of $1B.
Our BOD chairman obviously thought $5.85 was a good price when the stock was trading above $7. Like the rest of us, it seems, he did not expect the recent hammering since the business continues to improve consistently.
What's more noteworthy about the decision is that It makes Amarin a potential buy-out candidate.
Amarin's likely inability to commercially exploit the new reality does not mean larger, more competent players will not see the possibilities. Since the pharma space is a dog-eat-dog world, I would not expect Amarin's continual commercial failures to go unnoticed.
"The ruling means Amarin can give doctors and others truthful accounts of medical studies of the drug for reducing moderately high blood fats even when the FDA hasn't approved it for such use."
How did we get to a point where the FDA can prevent a company sharing the results of drug trials with doctors?
This ruling shows just how screwed up the regulatory side of drug development has become.
Time for an overhaul, perhaps the FDA needs to be taken apart and rebuilt using more sane principles.